ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

FibroGen, Inc - Common Stock (NQ:FGEN)

9.710 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	9.710
Bid (Size)	9.640 (100)
Ask (Size)	9.750 (500)
Prev. Close	9.710
Today's Range	9.710 - 9.710
52wk Range	0.2423 - 12.60
Shares Outstanding	98,210,168
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

FibroGen Inc (NASDAQ:FGEN) Stock Rises on Q3 2025 Earnings Beat and Strategic Updates ↗

November 10, 2025

FibroGen stock rose after a Q3 2025 earnings beat and the $220M sale of its China operations to AstraZeneca, boosting its financial position.

Via Chartmill

Fibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZeneca ↗

August 18, 2025

Via Stocktwits

Performance

YTD	+6.0%	+6.0%
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	+11.6%	+11.6%
1 Year	+3073.2%	+3073.2%

More News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 11, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

August 11, 2025

Via Chartmill

Uncovering Potential: FibroGen's Earnings Preview ↗

August 08, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports

August 11, 2025

Via MarketMinute

Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz ↗

July 08, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 02, 2025

Via Benzinga

A Preview Of FibroGen's Earnings ↗

May 09, 2025

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

June 13, 2025

Via Benzinga

Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

June 13, 2025

Via Benzinga

Adobe, RH And 3 Stocks To Watch Heading Into Friday ↗

June 12, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

June 12, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 19, 2025

Via Benzinga

Earnings Scheduled For March 17, 2025 ↗

March 17, 2025

Via Benzinga

What's going on in today's pre-market session ↗

February 25, 2025

Via Chartmill

On Friday, there are stocks with unusual volume. Let's take a look. ↗

February 21, 2025

Via Chartmill

What's going on in today's session ↗

February 20, 2025

Via Chartmill

Thursday's session: most active stocks ↗

February 20, 2025

Via Chartmill

Top movers in Thursday's session ↗

February 20, 2025

Via Chartmill

Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million ↗

February 20, 2025

Via Benzinga

Frequently Asked Questions

Is FibroGen, Inc - Common Stock publicly traded?

Yes, FibroGen, Inc - Common Stock is publicly traded.

What exchange does FibroGen, Inc - Common Stock trade on?

FibroGen, Inc - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for FibroGen, Inc - Common Stock?

The ticker symbol for FibroGen, Inc - Common Stock is FGEN on the Nasdaq Stock Market

What is the current price of FibroGen, Inc - Common Stock?

The current price of FibroGen, Inc - Common Stock is 9.710

When was FibroGen, Inc - Common Stock last traded?

The last trade of FibroGen, Inc - Common Stock was at 01/07/26 04:00 PM ET

What is the market capitalization of FibroGen, Inc - Common Stock?

The market capitalization of FibroGen, Inc - Common Stock is 953.62M

How many shares of FibroGen, Inc - Common Stock are outstanding?

FibroGen, Inc - Common Stock has 954M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.